Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Dementia”

490 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 490 results

Early research (Phase 1)Study completedNCT03113812
What this trial is testing

Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Araclon Biotech S.L. 24
Testing effectiveness (Phase 2)Study completedNCT03507790
What this trial is testing

Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

Who this might be right for
Mild to Moderate Alzheimer's Disease
Cognition Therapeutics 153
Testing effectiveness (Phase 2)Ended earlyNCT00895895
What this trial is testing

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

Who this might be right for
Alzheimer Disease
Pfizer 526
Large-scale testing (Phase 3)WithdrawnNCT00743743
What this trial is testing

Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Medical College of Wisconsin
Testing effectiveness (Phase 2)Ended earlyNCT00334568
What this trial is testing

Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 12
Post-approval studies (Phase 4)Study completedNCT00202124
What this trial is testing

Double Blind Study of Trp01 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Queen's University 12
Testing effectiveness (Phase 2)Study completedNCT00566397
What this trial is testing

Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 402
Testing effectiveness (Phase 2)UnknownNCT06185543
What this trial is testing

A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.

Who this might be right for
Alzheimer Disease
NeuroSense Therapeutics Ltd. 20
Large-scale testing (Phase 3)Study completedNCT00322153
What this trial is testing

The Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Dementia of the Alzheimer's Type
Forest Laboratories 677
Testing effectiveness (Phase 2)WithdrawnNCT03959553
What this trial is testing

GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD)

Who this might be right for
Moderate Alzheimer's Disease
GemVax & Kael
Early research (Phase 1)Study completedNCT02640092
What this trial is testing

Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT06881836
What this trial is testing

ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ono Pharmaceutical Co. Ltd 240
Large-scale testing (Phase 3)Study completedNCT02453932
What this trial is testing

Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia

Who this might be right for
Vascular Dementia
Dongzhimen Hospital, Beijing 543
Not applicableUnknownNCT04938271
What this trial is testing

A Telehealth Study of a Wearable Electroceutical & Sports Sleeve for Knee Osteoarthritis Pain Relief & Improved Function

Who this might be right for
Osteoarthritis, Knee
Healables Ltd. 24
Post-approval studies (Phase 4)UnknownNCT06093451
What this trial is testing

Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder

Who this might be right for
Schizophrenia AgitationSchizo Affective DisorderBipolar Disorder+1 more
Temple University 32
Large-scale testing (Phase 3)Ended earlyNCT01066546
What this trial is testing

An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 5
Early research (Phase 1)Study completedNCT01908010
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
AbbVie 20
Testing effectiveness (Phase 2)Study completedNCT01782742
What this trial is testing

Bexarotene Amyloid Treatment for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
The Cleveland Clinic 20
Testing effectiveness (Phase 2)Study completedNCT04491006
What this trial is testing

ATH-1017 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia of Alzheimer Type
Athira Pharma 77
Not applicableStudy completedNCT02711683
What this trial is testing

DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil

Who this might be right for
Alzheimer's Disease
First Affiliated Hospital Xi'an Jiaotong University 92
Load More Results